Literature DB >> 23417739

Low density lipoprotein delays clearance of triglyceride-rich lipoprotein by human subcutaneous adipose tissue.

Simon Bissonnette1, Huda Salem, Hanny Wassef, Nathalie Saint-Pierre, Annie Tardif, Alexis Baass, Robert Dufour, May Faraj.   

Abstract

Delayed clearance of triglyceride-rich lipoprotein (TRL) by white adipose tissue (WAT) promotes hypertriglyceridemia and elevated apoB-lipoproteins, which are primarily in the form of LDL. This study examines whether LDL promotes delayed clearance of TRL by WAT. Following the ingestion of a (13)C-triolein-labeled high-fat meal, obese women with high plasma apoB (> median 0.93 g/l, N = 11, > 98% as IDL/LDL) had delayed clearance of postprandial (13)C-triglyceride and (13)C-NEFA over 6 h compared with controls. AUC6 h of plasma (13)C-triglyceride and (13)C-NEFA correlated with plasma apoB but not with LDL diameter or adipocyte area. There was no group difference in (13)C-triolein oxidation rate, which suggests lower (13)C-NEFA storage in peripheral tissue in women with high apoB. Ex vivo/in vitro plasma apoB correlated negatively with WAT (3)H-lipid following a 4 h incubation of women's WAT with synthetic (3)H-triolein-TRL. LDL-differentiated 3T3-L1 adipocytes had lower (3)H-TRL hydrolysis and (3)H-NEFA storage. Treatment of women's WAT with their own LDL decreased (3)H-TRL hydrolysis and (3)H-NEFA uptake. Finally, LDL, although not an LPL substrate, reduced LPL-mediated (3)H-TRL hydrolysis as did VLDL and HDL. Exposure to LDL decreases TRL clearance by human WAT ex vivo. This may promote production of apoB-lipoproteins and hypertriglyceridemia through a positive-feedback mechanism in vivo.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23417739      PMCID: PMC3622338          DOI: 10.1194/jlr.P023176

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  67 in total

1.  Estimation of the low-density lipoprotein (LDL) subclass phenotype using a direct, automated assay of small dense LDL-cholesterol without sample pretreatment.

Authors:  Annemie Vandermeersch; Sara Ameye; Dieter Puype; Dominique Petitjean; Marc De Buyzere; Michel R Langlois
Journal:  Clin Chim Acta       Date:  2010-06-02       Impact factor: 3.786

2.  Impaired chylomicron remnant clearance in familial combined hyperlipidemia.

Authors:  M C Cabezas; T W de Bruin; H Jansen; L A Kock; W Kortlandt; D W Erkelens
Journal:  Arterioscler Thromb       Date:  1993-06

Review 3.  Electronegative low-density lipoprotein: origin and impact on health and disease.

Authors:  Ana Paula Queiroz Mello; Isis Tande da Silva; Dulcineia Saes Parra Abdalla; Nágila Raquel Teixeira Damasceno
Journal:  Atherosclerosis       Date:  2011-01-19       Impact factor: 5.162

4.  Reduction in serum apoB is associated with reduced inflammation and insulin resistance in post-menopausal women: A MONET study.

Authors:  May Faraj; Marie-Eve Lavoie; Lyne Messier; Jean-Philippe Bastard; Denis Prud'homme
Journal:  Atherosclerosis       Date:  2010-04-21       Impact factor: 5.162

5.  Synthesis and secretion of apoC-I and apoE during maturation of human SW872 liposarcoma cells.

Authors:  Hanny Wassef; Lise Bernier; Jean Davignon; Jeffrey S Cohn
Journal:  J Nutr       Date:  2004-11       Impact factor: 4.798

6.  Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals.

Authors:  G F Lewis; K D Uffelman; L W Szeto; G Steiner
Journal:  Diabetes       Date:  1993-06       Impact factor: 9.461

7.  Regulation of hepatic apolipoprotein B-lipoprotein assembly and secretion by the availability of fatty acids. I. Differential response to the delivery of fatty acids via albumin or remnant-like emulsion particles.

Authors:  Yuan-Li Zhang; Antonio Hernandez-Ono; Carol Ko; Koichi Yasunaga; Li-Shin Huang; Henry N Ginsberg
Journal:  J Biol Chem       Date:  2004-02-17       Impact factor: 5.157

8.  Differential regulation of fatty acid trapping in mouse adipose tissue and muscle by ASP.

Authors:  May Faraj; Katherine Cianflone
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-07       Impact factor: 4.310

9.  Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins].

Authors:  A Sniderman; S Shapiro; D Marpole; B Skinner; B Teng; P O Kwiterovich
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

10.  The effects of bovine serum albumin and oleic acid on rat pancreatic lipase and bovine milk lipoprotein lipase.

Authors:  I Posner; J DeSanctis
Journal:  Comp Biochem Physiol B       Date:  1987
View more
  7 in total

1.  The Association of Polyunsaturated Fatty Acid δ-5-Desaturase Activity with Risk Factors for Type 2 Diabetes Is Dependent on Plasma ApoB-Lipoproteins in Overweight and Obese Adults.

Authors:  Valérie Lamantia; Simon Bissonnette; Viviane Provost; Marie Devaux; Yannick Cyr; Caroline Daneault; Christine Des Rosiers; May Faraj
Journal:  J Nutr       Date:  2019-01-01       Impact factor: 4.798

Review 2.  Hypercholesterolemia induces adipose dysfunction in conditions of obesity and nonobesity.

Authors:  David Aguilar; Maria Luz Fernandez
Journal:  Adv Nutr       Date:  2014-09       Impact factor: 8.701

3.  WAT apoC-I secretion: role in delayed chylomicron clearance in vivo and ex vivo in WAT in obese subjects.

Authors:  Yannick Cyr; Hanny Wassef; Simon Bissonnette; Valerie Lamantia; Jean Davignon; May Faraj
Journal:  J Lipid Res       Date:  2016-04-03       Impact factor: 5.922

4.  Elevated Levels of Apolipoprotein CIII Increase the Risk of Postprandial Hypertriglyceridemia.

Authors:  Yunpeng Guan; Xiaoyu Hou; Peipei Tian; Luping Ren; Yong Tang; An Song; Jiajun Zhao; Ling Gao; Guangyao Song
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-23       Impact factor: 5.555

5.  Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial.

Authors:  Tatsuya Ohara; Koutarou Muroyama; Yoshihiro Yamamoto; Shinji Murosaki
Journal:  Nutr J       Date:  2016-01-19       Impact factor: 3.271

6.  Lower plasma PCSK9 in normocholesterolemic subjects is associated with upregulated adipose tissue surface-expression of LDLR and CD36 and NLRP3 inflammasome.

Authors:  Yannick Cyr; Valérie Lamantia; Simon Bissonnette; Melanie Burnette; Aurèle Besse-Patin; Annie Demers; Martin Wabitsch; Michel Chrétien; Gaétan Mayer; Jennifer L Estall; Maya Saleh; May Faraj
Journal:  Physiol Rep       Date:  2021-02

7.  Plasma IL-1Ra: linking hyperapoB to risk factors for type 2 diabetes independent of obesity in humans.

Authors:  S Bissonnette; N Saint-Pierre; V Lamantia; Y Cyr; H Wassef; M Faraj
Journal:  Nutr Diabetes       Date:  2015-09-28       Impact factor: 5.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.